Lu et al. recently reported that IRF6 is downregulated in glioma, with the Lin28A/SNHG14/IRF6 axis reprogramming glucose metabolism and stimulating tumorigenesis in glioma cells [13]. This evidence concerns the gene LIN28A and central nervous system cancer.